A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

450 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-31

Study Completion Date

2010-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study taking swabs from the back of the nose (nasopharynx) to look at carriage of pneumococci.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Assess the Carriage of Pneumococci in Children Aged ≤8 Years, and Their Household Contacts

NCT03407690

Immunization; Infection

COMPLETED

A Study to Assess the Carriage of Pneumococci in Children Aged 1-5 Years, and Their Household Contacts

NCT02522546

Nasal Carriage of Pneumococci

COMPLETED

Understanding Pneumococcal Carriage and Disease 2017-2020

NCT03102840

Streptococcus Pneumoniae Infection Streptococcus Pneumoniae, Invasive Disease Streptococcal Pneumonia

UNKNOWN

Paediatric Post Pneumococcal Conjugate Vaccine Nasopharyngeal Carriage Study

NCT04401488

S. Pneumoniae Pneumococcal Conjugate Vaccine

UNKNOWN

Nasopharyngeal Carriage of S. Pneumoniae

NCT04460313

Nasopharyngeal Carriage Children, Only Antibiotic Resistant Strain

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumococcal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Born in a cohort eligible for routine or catch up pneumococcal conjugate vaccination (i.e. date of birth since 4th September 2004) or a family member where a child is eligible and has been enrolled
* Written informed consent given by the subject's parent/ legal guardian as well as assent from the child after the nature of the study has been explained to them or
* Written informed consent given by the subject after the nature of the study has been explained to them

Exclusion Criteria

* Moderate to severe disability.
* Cerebral palsy, syndromes and neurological disorders affecting swallowing.
* Ear Nose and Throat disorders affecting the anatomy of the ear,i.e.malformed ears.
* Confirmed or suspected immunodeficiency (congenital or acquired).
* On immunosuppressive therapy.

Minimum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes